Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of oral dronedarone on rivaroxaban plasma concentration in atrial fibrillation
ChiCTR2300069986Phase 4Not yet recruiting
- Sponsor
- Shanghai Changzheng Hospital
- Start
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in Atrial fibrillation (AFib) comparing dronedarone + rivaroxaban with Control: rivaroxaban alone (2 arms). Primary endpoints: Peak rivaroxaban plasma concentration at 1 week, Trough rivaroxaban plasma concentration at 1 week and 2 more. Planned start Mar 2023; status: not yet recruiting.
02
Drugs
dronedaronerivaroxaban
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on ChiCTR2300069986.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300069986.